Enzalutamide Enzalutagen 40 mg by Genygi Life

Share our Advanced Products

Responding to the alarming rise in cancer cases worldwide, Genygi Life is proud to introduce a New Line of innovative medications designed to combat cancer at the forefront of scientific advancement.

#

Enzalutamide Enzalutagen-40

Enzalutamide is а second-generation androgen receptor inhibitor used to treat castration-resistant prostate cancer and metastatic castration-sensitive prostate cancer

#

Abirateron Abiragen-250

It is an antitumor agent prescribed for the treatment of prostate cancer.

#

Imatinib Imatigen-100, Imatigen-400

Imatinib is used to treat chronic myelogenous leukemia (CML), gastrointestinal stromal tumors (GISTs), and several other malignancies.

#

Sunitinib Sunitigen-25, Sunitigen-50

Advanced and/or metastatic renal cell carcinoma (including cases where cytokine therapy has been ineffective).

#

Sorafenib Sorafgen-200

Sorafenib is indicated as a treatment for advanced renal cell carcinoma (RCC), unresectable hepatocellular carcinomas (HCC) and thyroid cancer.

#

Tamoxifen Tamoxigen-20

Tamoxifen is effective in treating estrogen-dependent cancers, primarily breast tumors.

Learn more
Download Presentation